Regulatory15 May 2026, 11:48 am
Natco Pharma: Receives ₹4.92 Cr Demand Notice from NPPA
AI Summary
Natco Pharma Ltd has received a demand notice dated May 12, 2026, from the National Pharmaceutical Pricing Authority (NPPA) for ₹4,92,25,923. The notice alleges overcharging for two drugs between April and November 2023. Natco Pharma reported that there is no material impact on the company's financial or operational activities. The company cited technical issues for the delay in disclosing the information.
Key Highlights
- Natco Pharma received a demand notice from NPPA for ₹4.92 Cr.
- The demand notice alleges overcharging for two drugs from April-Nov 2023.
- Natco Pharma states no material financial or operational impact.
- Delay in disclosure was due to technical issues/procedural delay.
Price Impact
More from NATCOPHARM